Ami Organics Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 21, 2024, 1:28 am

Market Cap	8,680 Cr.
Current Price	2,120
High / Low	2,320/1,004
Stock P/E	92.9
Book Value	294
Dividend Yield	0.14 %
ROCE	16.0 %
ROE	9.37 %
Face Value	10.0
PEG Ratio	-8.57

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for

Competitors of

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Gujarat Themis Biosyn Ltd	3,354 Cr.	308	390/128	63.6	20.5	0.22 %	45.0 %	33.8 %	1.00
Gujarat Terce Laboratories Ltd	62.6 Cr.	84.4	94.9/26.6	24.0	11.9	0.00 %	9.72 %	3.44 %	10.0
Gujarat Inject (Kerala) Ltd	35.9 Cr.	24.5	24.5/8.74	46.6	6.64	0.00 %	2.65 %	2.08 %	10.0
Godavari Drugs Ltd	86.7 Cr.	115	155/87.0	13.0	55.4	0.00 %	14.4 %	15.5 %	10.0
Glenmark Life Sciences Ltd	12,416 Cr.	1,013	1,335/645	29.3	207	2.22 %	28.1 %	21.1 %	2.00
Industry Average	19,016.52 Cr	1,181.31		56.05	186.30	0.32%	16.20%	16.32%	6.27

All Competitor Stocks of

Quarterly Result

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	122	141	144	131	147	152	186	154	172	166	225	177	247
Expenses	95	111	118	108	119	122	146	120	148	140	182	147	198
Operating Profit	27	30	26	23	28	31	41	34	25	27	43	30	49
OPM %	22%	21%	18%	17%	19%	20%	22%	22%	14%	16%	19%	17%	20%
Other Income	0	1	0	1	1	3	-0	1	-30	3	1	1	8
Interest	3	0	1	0	0	1	1	1	1	3	2	4	0
Depreciation	2	2	3	3	3	3	3	4	4	4	5	6	7
Profit before tax	23	29	22	20	26	30	37	31	-10	24	37	20	50
Tax %	22%	32%	4%	27%	26%	25%	26%	28%	71%	25%	31%	26%	25%
Net Profit	17	19	21	15	19	22	27	22	-17	18	26	15	38
EPS in Rs	4.79	5.34	5.84	4.08	5.23	6.11	7.46	5.41	-5.11	4.54	6.82	3.41	9.12

Last Updated: November 6, 2024, 7:21 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: October 23, 2024, 3:10 pm

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	160	188	239	240	341	520	617	717	740
Expenses	137	157	196	198	260	415	493	589	616
Operating Profit	23	31	42	42	80	105	123	128	124
OPM %	14%	16%	18%	17%	24%	20%	20%	18%	17%
Other Income	0	3	0	2	1	3	4	-25	-25
Interest	3	3	5	6	6	6	2	6	10
Depreciation	1	2	3	4	4	10	12	16	19
Profit before tax	19	28	35	35	72	91	112	82	71
Tax %	35%	35%	34%	21%	25%	21%	26%	41%
Net Profit	12	18	23	27	54	72	83	49	41
EPS in Rs	80.33	123.33	22.19	26.16	17.14	19.75	22.86	11.60	9.66
Dividend Payout %	0%	0%	0%	0%	0%	15%	13%	26%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	50.00%	27.78%	17.39%	100.00%	33.33%	15.28%	-40.96%
Change in YoY Net Profit Growth (%)	0.00%	-22.22%	-10.39%	82.61%	-66.67%	-18.06%	-56.24%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	25%
3 Years:	28%
TTM:	23%

Compounded Profit Growth
10 Years:	%
5 Years:	21%
3 Years:	3%
TTM:	22%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	30%
1 Year:	77%

Return on Equity
10 Years:	%
5 Years:	17%
3 Years:	14%
Last Year:	9%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 5:54 pm

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	2	2	10	10	32	36	36	37	41
Reserves	37	56	72	101	135	486	558	637	1,161
Borrowings	27	44	54	59	137	1	4	217	6
Other Liabilities	43	54	77	61	110	136	169	205	219
Total Liabilities	109	155	213	232	413	659	767	1,096	1,427
Fixed Assets	28	32	79	85	186	205	259	427	421
CWIP	11	30	2	12	0	3	30	125	189
Investments	1	3	2	2	1	2	2	0	0
Other Assets	68	91	131	133	225	450	477	543	817
Total Assets	109	155	213	232	413	659	767	1,096	1,427

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	29	8	15	27	28	-12	66	125
Cash from Investing Activity +	-19	-25	-21	-24	-101	-121	-33	-365
Cash from Financing Activity +	-7	15	6	0	72	140	-12	239
Net Cash Flow	3	-2	-0	3	-1	8	20	-1

Free Cash Flow

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-4.00	-13.00	-12.00	-17.00	-57.00	104.00	119.00	-89.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	83	97	116	86	129	115	136	105
Inventory Days	76	89	95	148	123	150	131	139
Days Payable	148	154	168	146	172	158	157	119
Cash Conversion Cycle	11	31	43	88	80	107	111	125
Working Capital Days	46	64	68	86	119	141	141	132
ROCE %		38%	34%	27%	33%	24%	21%	16%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	41.05%	41.05%	41.05%	41.05%	39.41%	39.41%	39.41%	39.41%	38.93%	39.91%	39.91%	35.98%
FIIs	2.51%	1.34%	2.23%	1.84%	5.76%	6.41%	6.36%	6.73%	7.15%	11.66%	8.98%	12.93%
DIIs	6.30%	3.81%	5.63%	4.20%	3.61%	3.73%	3.63%	5.12%	5.95%	7.58%	6.80%	14.81%
Public	50.14%	53.80%	51.08%	52.91%	51.22%	50.47%	50.62%	48.74%	47.97%	40.85%	44.31%	36.28%
No. of Shareholders	92,459	97,547	93,922	87,044	85,563	80,531	78,786	70,352	72,897	83,344	95,784	90,987

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund	441,022	1.44	51.31	50,000	2024-12-17	782.04%
UTI Small Cap Fund	324,226	1.01	37.72	50,000	2024-12-17	548.45%
Tata ELSS Tax Saver Fund	298,000	0.87	34.67	50,000	2024-12-17	496%
ITI Small Cap Fund	145,802	0.81	16.96	50,000	2024-12-17	191.6%
Union Small Cap Fund	117,713	1.02	13.69	50,000	2024-12-17	135.43%
UTI Healthcare Fund	110,000	1.39	12.8	50,000	2024-12-17	120%
Edelweiss Recently Listed IPO Fund	100,000	1.24	11.63	50,000	2024-12-17	100%
Tata India Pharma & HealthCare Fund	50,000	0.69	5.82	50,000	2024-12-17	0%
Taurus Infrastructure Fund	335	0.48	0.04	50,000	2024-12-17	-99.33%
Motilal Oswal S&P BSE Healthcare ETF	157	0.18	0.02	50,000	2024-12-17	-99.69%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	11.67	22.86	21.03	17.14	8.72
Diluted EPS (Rs.)	11.66	22.86	21.03	17.14	8.72
Cash EPS (Rs.)	17.56	26.25	22.51	18.47	29.51
Book Value[Excl.RevalReserv]/Share (Rs.)	185.13	163.01	143.34	52.99	106.49
Book Value[Incl.RevalReserv]/Share (Rs.)	185.13	163.01	143.34	52.99	106.49
Revenue From Operations / Share (Rs.)	194.54	169.26	142.75	108.13	228.23
PBDIT / Share (Rs.)	36.87	34.83	29.62	25.88	41.77
PBIT / Share (Rs.)	32.52	31.45	26.86	24.55	38.42
PBT / Share (Rs.)	22.21	30.79	25.10	22.77	33.10
Net Profit / Share (Rs.)	13.21	22.86	19.75	17.14	26.16
NP After MI And SOA / Share (Rs.)	11.60	22.86	19.75	17.14	26.16
PBDIT Margin (%)	18.95	20.58	20.75	23.93	18.30
PBIT Margin (%)	16.71	18.57	18.81	22.70	16.83
PBT Margin (%)	11.41	18.18	17.58	21.05	14.50
Net Profit Margin (%)	6.78	13.50	13.83	15.85	11.46
NP After MI And SOA Margin (%)	5.96	13.50	13.83	15.85	11.46
Return on Networth / Equity (%)	6.34	14.02	13.77	32.34	24.56
Return on Capital Employeed (%)	14.79	18.96	18.47	31.28	29.38
Return On Assets (%)	3.90	10.86	10.91	13.06	11.84
Long Term Debt / Equity (X)	0.16	0.00	0.00	0.43	0.17
Total Debt / Equity (X)	0.32	0.01	0.00	0.70	0.48
Asset Turnover Ratio (%)	0.77	0.86	0.97	1.06	1.09
Current Ratio (X)	1.74	2.89	3.32	1.30	1.28
Quick Ratio (X)	1.19	2.15	2.45	0.93	0.72
Inventory Turnover Ratio (X)	3.19	2.99	3.27	3.10	3.03
Dividend Payout Ratio (NP) (%)	25.55	13.12	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	18.58	11.43	0.00	0.00	0.00
Earning Retention Ratio (%)	74.45	86.88	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	81.42	88.57	0.00	0.00	0.00
Interest Coverage Ratio (X)	22.89	52.62	16.85	14.51	7.85
Interest Coverage Ratio (Post Tax) (X)	14.60	35.53	12.23	10.61	5.92
Enterprise Value (Cr.)	4208.12	3184.01	3543.73	0.00	0.00
EV / Net Operating Revenue (X)	5.87	5.16	6.81	0.00	0.00
EV / EBITDA (X)	30.95	25.09	32.83	0.00	0.00
MarketCap / Net Operating Revenue (X)	5.63	5.25	7.00	0.00	0.00
Retention Ratios (%)	74.44	86.87	0.00	0.00	0.00
Price / BV (X)	5.99	5.45	6.97	0.00	0.00
Price / Net Operating Revenue (X)	5.63	5.25	7.00	0.00	0.00
EarningsYield	0.01	0.02	0.01	0.00	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of December 22, 2024 is: 2,562.77

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 22, 2024, is Undervalued by 20.89% compared to the current share price 2,120.00

Intrinsic Value of as of December 22, 2024 is: 2,285.09

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 22, 2024, is Undervalued by 7.79% compared to the current share price 2,120.00

Last 5 Year EPS CAGR: -10.84%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 24.13%, which is a positive sign. The company has higher reserves (360.33 cr) compared to borrowings (61.00 cr), indicating strong financial stability. The company has shown consistent growth in sales (418.00 cr) and profit (60.56 cr) over the years.	The stock has a high average Working Capital Days of 99.63, which may not be favorable. The stock has a high average Cash Conversion Cycle of 74.50, which may not be favorable.

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
1. Net Profit Margin: 6.78%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 14.79% (Industry Average ROCE: 16.2%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 6.34% (Industry Average ROE: 16.32%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 14.6
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.19
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 92.9 (Industry average Stock P/E: 56.05)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.32
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Ami Organics Ltd. is a Public Limited Listed company incorporated on 12/06/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2007PLC051093 and registration number is 051093. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 520.14 Cr. and Equity Capital is Rs. 36.44 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	Plot No. 440/4, 5 & 6, Surat Gujarat 394230	investorinfo@amiorganics.com http://www.amiorganics.com

Management
Name	Position Held
Mr. Nareshkumar Ramjibhai Patel	Exe.Chairman & Mng.Director
Mr. Virendra Nath Mishra	Whole Time Director
Mr. Ram Mohan Rao Locande	Whole Time Director
Mr. Chetankumar Chhaganlal Vaghasia	Whole Time Director
Mr. Hetal Madhukant Gandhi	Independent Director
Mr. Girikrishna Suryakant Maniar	Independent Director
Mrs. Richa Manoj Goyal	Independent Director
Dr. Anita Bandyopadhyay	Independent Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 22 December 2024 is ₹2562.77, which is 20.89% higher than the current market price of ₹2,120.00. The stock has a market capitalization of 8,680 Cr. and recorded a high/low of 2,320/1,004 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,161 Cr and total liabilities of ₹1,427 Cr.

What is the Market Cap of ?

The Market Cap of is 8,680 Cr..

What is the current Stock Price of as on 22 December 2024?

The current stock price of as on 22 December 2024 is 2,120.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 2,320/1,004.

What is the Stock P/E of ?

The Stock P/E of is 92.9.

What is the Book Value of ?

The Book Value of is 294.

What is the Dividend Yield of ?

The Dividend Yield of is 0.14 %.

What is the ROCE of ?

The ROCE of is 16.0 %.

What is the ROE of ?

The ROE of is 9.37 %.

What is the Face Value of ?

The Face Value of is 10.0.